Poland
# |
Name |
Net Cash Used Provided By Financing Activities |
Reported Date | Stock Price |
Change |
Price (30 days) | Country |
---|---|---|---|---|---|---|---|
1 |
USD 61.07 M
|
Dec. 31, 2023 | USD 6.53 | 2.36% |
|
Poland |
|
2 |
USD 13.88 M
|
Dec. 31, 2023 | USD 2.23 | -2.90% |
|
Poland |
|
3 |
USD 13.52 M
|
Dec. 31, 2023 | USD 1.13 | -2.47% |
|
Poland |
|
4 |
USD 9.37 M
|
Dec. 31, 2023 | USD 12.20 | -4.46% |
|
Poland |
|
5 |
USD 8.75 M
|
Dec. 31, 2023 | USD 2.23 | -2.59% |
|
Poland |
|
6 |
USD 6.14 M
|
Dec. 31, 2023 | USD 3.74 | -3.55% |
|
Poland |
|
7 |
USD 5.27 M
|
Dec. 31, 2023 | USD 9.53 | 2.20% |
|
Poland |
|
8 |
USD 5.17 M
|
Dec. 31, 2023 | USD 20.96 | 2.85% |
|
Poland |
|
9 |
USD 2.99 M
|
Dec. 31, 2023 | USD 1.76 | -3.29% |
|
Poland |
|
10 |
USD 1.64 M
|
Dec. 31, 2023 | USD 0.74 | -0.78% |
|
Poland |
|
11 |
USD -77.34 K
|
Dec. 31, 2023 | USD 0.28 | -6.36% |
|
Poland |
|
12 |
USD -175.23 K
|
Dec. 31, 2023 | USD 1.79 | -1.96% |
|
Poland |
|
13 |
USD -712.33 K
|
Dec. 31, 2023 | USD 5.31 | 1.06% |
|
Poland |
|
14 |
USD -2.06 M
|
Dec. 31, 2023 | USD 0.86 | -4.13% |
|
Poland |
|
15 |
USD -3.31 M
|
Dec. 31, 2023 | USD 2.81 | -1.43% |
|
Poland |
|
16 |
USD -5.22 M
|
Dec. 31, 2023 | USD 5.78 | -2.65% |
|
Poland |
|
17 |
USD -7.85 M
|
Dec. 31, 2023 | USD 10.51 | -3.97% |
|
Poland |
|
18 |
USD -8.67 M
|
Sept. 30, 2024 | USD 51.90 | -3.89% |
|
Poland |
|
19 |
USD -10.34 M
|
Dec. 31, 2023 | USD 5.23 | -1.43% |
|
Poland |
|
20 |
USD -12.14 M
|
Dec. 31, 2023 | USD 34.85 | -3.77% |
|
Poland |
|
21 |
USD -35.27 M
|
Dec. 31, 2023 | USD 206.65 | -0.03% |
|
Poland |
|
22 |
USD -59.40 M
|
Dec. 31, 2023 | USD 39.15 | -2.15% |
|
Poland |
The Healthcare company in Poland with the highest Net Cash Used Provided By Financing Activities is Ryvu Therapeutics S.A. (Warsaw Stock Exchange: RVU.WA) at USD 61.07 M.
The Healthcare company in Poland with the lowest Net Cash Used Provided By Financing Activities is Scope Fluidics S.A. (Warsaw Stock Exchange: SCP.WA) at USD -59.40 M.
The top 10 Healthcare companies in Poland by Net Cash Used Provided By Financing Activities are Ryvu Therapeutics S.A., Molecure S.A., Synthaverse S.A., Captor Therapeutics Spolka Akcyjna, Mabion S.A., Pure Biologics Spólka Akcyjna, Poltreg S.A., Bioceltix S.A., Genomtec S.A. and NanoGroup S.A..
The bottom 10 Healthcare companies in Poland by Net Cash Used Provided By Financing Activities are Scope Fluidics S.A., NEUCA S.A., Voxel S.A., Centrum Medyczne ENEL-MED S.A., Synektik Spólka Akcyjna, Selvita S.A., Celon Pharma S.A., EMC Instytut Medyczny SA, BIOTON S.A. and Medicalgorithmics S.A..